Tucatinib is a small-molecule inhibitor of HER2 used as an active pharmaceutical ingredient in the manufacturing of anticancer therapies. It is primarily researched for its role in targeting HER2-positive breast cancer.
内容范围: 本页信息面向化学品识别与工业供应、研发、生产场景，不构成疗效宣称、医疗建议或药品使用指导。
1-(1-hydroxy-2-methylpropan-2-yl)-3-[4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)anilino]quinazolin-6-yl]thiourea
HZCZAJGNAXZBTF-UHFFFAOYSA-N
CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC(=S)NC(C)(C)CO)OC4=CC5=NC=NN5C=C4